Controversies over the moral justification for patent protection in biotechnology
DOI:
https://doi.org/10.18778/1899-2226.21.5.05Słowa kluczowe:
moral justification, patents, biotechnologyAbstrakt
This paper discusses the controversies over the moral justification for patent protection in biotechnology. Special emphasis has been put on the controversy over the moral justification for patent protection of stem cells. By referring to arguments for (1) human dignity and (2) patentability criteria, the moral justifiability of patent protection of stem cells is in serious doubt. A whole section of the paper is devoted to the moral issues linked to patent protection in biotechnology and their political and economic significance. An attempt is made to solve some of the discussed problems, i.e., the introduction of decision criteria based on the system of values shared by the members of a given society.
Bibliografia
Alison, M. R., Poulsom, R., Forbes, S., & Wright N. A. (2002). An introduction to stem cells. Review, Journal of Pathology, 197, 419–423.
Google Scholar
Andorno, R. (2009). Human dignity and human rights as a common ground for a global ethics. Journal of Medicine and Philosophy, 34, 223–240.
Google Scholar
Bahadur, G., & Morrison, M. (2010). Patenting human pluripotent cells: Balancing commercial, academic and ethical interests. Human Reproduction, 25, 14–21.
Google Scholar
Bishop, A. E., Lee, D. K., & Polak, J. M. (2002). Embryonic stem cells. Review. Journal of Pathology, 197, 424–429.
Google Scholar
Blau, H. M., Brazelton, T. R., & Weissman, J. M. (2001). The evolving concept of stem cell: entity or function. Cell, 105, 829–841.
Google Scholar
Boldrin, M., & Levine, D. K. (2013). The case against patents. Journal of Economic Perspectives, 27, 3–22.
Google Scholar
Chakma, J., Sammut, S. M., & Agrawal, A. (2013). Life sciences venture capital in emerging markets. Nature Biotechnology, 31, 195–201.
Google Scholar
Cogle, C. R., Guthrie, S. M., Sanders, R. C., Allen, W. L., Scott, E. W., & Petersen, B. E. (2003). An overview of stem cell research and regulatory issues. Mayo Clin. Proc., 8, 993–1003.
Google Scholar
Devaiah, V. H. (2010). Impact of bioethics on patentability of inventions. Indian Journal of Medical Ethics, 7, 14–17.
Google Scholar
Drahos, P. (1999). Biotechnology patents, markets and morality. E.I.P.R., 21, 441–449.
Google Scholar
Grubb, P. W. (2004). Patents for chemicals, pharmaceuticals and biotechnology: Fundamentals of global law, practice and strategy. Oxford University Press.
Google Scholar
Habermas, J. (2003). Przyszłość natury ludzkiej. Czy zmierzamy do eugeniki liberalnej? Warszawa: Scholar.
Google Scholar
Holland, S., Lebacqz, K., & Zoloth, L. (2001). The human embryonic stem cel debate: Science, ethics, and public policy. Cambridge: MIT Press.
Google Scholar
Inoue, H., Nagata, N., Kurokawa, H., & Yamanaka, S. (2014). iPS cells: a game changer for future medicine. EMBO Journal, 33, 409–417.
Google Scholar
Kamieniarz, K., Nawrot, R., Grajek, K., & Goździcka-Józefiak, A. (2006). Biotechnologia w medycynie regeneracyjnej i reprodukcyjnej. Biotechnologia, 73, 31–48.
Google Scholar
Kant, I. (2014). Uzasadnienie metafizyki moralności. Kęty: Wydawnictwo Marek Derewiecki.
Google Scholar
Karbowski, A. (2017). Kontrowersje związane z moralnym uzasadnieniem ochrony patentowej w biotechnologii. Annales. Ethics in Economic Life, 20(1), 83–94.
Google Scholar
Karbowski, A., & Prokop, J. (2013). Controversy over the economic justifications for patent protection. Procedia – Economics and Finance, 5, 393–402.
Google Scholar
Khachiauri, S. (2012). Human embryonic stem cell controversy (Patents involving ethical and human rights concern). Lund University.
Google Scholar
Krueger, A. O. (1974). The political economy of the rent-seeking society. American Economic Review, 64, 291–303.
Google Scholar
Lemke, T. (2010). Biopolityka (T. Dominiak, Trans.). Warszawa: Sic!
Google Scholar
Liberda, Z. B. (2008). Patenty w skali światowej i w poszczególnych krajach. In A. Zachorowska-Mazurkiewicz, & E. Okoń-Horodyńska (Eds.), Tendencje innowacyjnego rozwoju polskich przedsiębiorstw. Warszawa: Instytut Wiedzy i Innowacji.
Google Scholar
Looney, B. (1994). Should genes be patented? Law and Policy in International Business, 26, 231–272.
Google Scholar
Machlup, F. (1958). An economic review of the patent system. Washington: United States Government Printing Office.
Google Scholar
Oman, R. (1995). Biotech patenting issues raise ethical concerns. National Law Journal, 17, C42.
Google Scholar
Puri, M. C., & Nagy, A. (2012). Concise review: Embryonic stem cells versus induced pluripotent stem cells: The game is on. Stem Cells, 30, 10–14.
Google Scholar
Resnik, D. B. (2004). Owning the genome: A moral analysis of DNA patenting. New York: State University of New York Press.
Google Scholar
Resnik, D. B. (2007). Embryonic stem cell patents and human dignity. Health Care Analysis, 15, 211–222.
Google Scholar
Rothhaar, M. (2010). Human dignity and human rights in bioethics: The Kantian approach. Medicine, Health Care and Philosophy, 13, 251–257.
Google Scholar
Senser, O. (2009). Kant’s conception of human dignity. Kant Studien, 100, 309–331.
Google Scholar
Sikora, M., & Olszewski, W. (2004). Komórki macierzyste – biologia i zastosowanie terapeutyczne. Postępy Higieny i Medycyny Doświadczalnej, 58, 202–208.
Google Scholar
Sterckx, S. (2006). The moral justifiability of patents. Ethical Perspectives: Journal of the European Ethics Network, 13, 249–265.
Google Scholar
Warrington, A. M. (1964). Private and public morality. Canadian Medical Association Journal, 90, 1326.
Google Scholar
Wiśniewska, J. (2008). Motywy podejmowania bezpośrednich inwestycji zagranicznych. Przegląd Organizacji, 12, 19–23.
Google Scholar
Wojciszke, B. (2011). Psychologia społeczna. Warszawa: Scholar.
Google Scholar
Yamanaka, S. (2012). Induced pluripotent stem cells: Past, present and future. Cell Stem Cell, 10, 678–684.
Google Scholar
Pobrania
Opublikowane
Jak cytować
Numer
Dział
Licencja
Prawa autorskie (c) 2018 Annales. Etyka w Życiu Gospodarczym
Utwór dostępny jest na licencji Creative Commons Uznanie autorstwa – Użycie niekomercyjne – Bez utworów zależnych 4.0 Międzynarodowe.
